Table 3.
Association between DPP4a and left ventricular systolic dysfunction in STEMI patients.
| Unadjusted | p Value | Model 1* | p Value | Model 2† | p value | |
|---|---|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | OR (95% CI) | ||||
| Left ventricular systolic dysfunction | ||||||
| T1 | 5.28 (2.27–12.28) | <0.01 | 5.31 (2.28–12.40) | <0.01 | 8.70 (3.15–24.05) | <0.01 |
| T2 | 3.21 (1.33–7.73) | 0.01 | 3.23 (1.34–7.79) | 0.01 | 4.87 (1.76–13.49) | <0.01 |
| T3 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | |||
| per 1 U/L | 0.93 (0.90–0.96) | <0.01 | 0.93 (0.90–0.96) | <0.01 | 0.90 (0.87–0.94) | <0.01 |
*Adjusted for age and sex.
†Adjusted for age, sex, body mass index, creatinine, gamma-glutamyltransferase, creatinine, MB isoenzyme of creatine kinase, pro- brain natriuretic peptide, hypertension, hyperlipemia, type 2 diabetes, smoking and previous myocardial infarction.